Nyxoah SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Nyxoah SA on November 5, 2024, covering the month of November 2024. The filing primarily reports on significant executive leadership changes within the company.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial statements or performance data.
Material Changes
- Appointment of CFO: John Landry was appointed as Chief Financial Officer, effective November 4, 2024. He previously served as SVP, CFO, and Treasurer at Vapotherm Inc. (2020–2024) and held various financial leadership roles at Medtronic, Salient Surgical Technologies, and Bottomline Technologies.
- Transition of Former CFO: Loic Moreau, the former CFO, is transitioning to the role of President International to lead the company's global expansion efforts.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, management commentary on financial performance, or specific risk factors. The strategic implication noted is the focus on global expansion under the new leadership structure.
Key Facts for Investor Verification
- Verify the effective date of John Landry's appointment as CFO (November 4, 2024).
- Confirm Loic Moreau's new title as President International and his role in global expansion.
- Note that this filing does not include updated financial results; investors should refer to the most recent Form 20-F or quarterly reports for financial data.